✦ LIBER ✦

Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism

✍ Scribed by Dr. Barry J. Snow; Torbjoern G. Nygaard; Hirohide Takahashi; Donald B. Calne

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 558 KB
Volume: 34
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410340518

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term treatment response and fluorod

Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia

✍ Dr. Torbjoern G. Nygaard; Hirohide Takahashi; Gary A. Heiman; Barry J. Snow; Sta 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

Longitudinal fluorodopa positron emissio

Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism

✍ F. J. G. Vingerhoets; Dr B. J. Snow; C. S. Lee; M. Schulzer; E. Mak; D. B. Calne 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Biochemical and fluorodopa positron emis

Biochemical and fluorodopa positron emission tomographic findings in an asymptomatic carrier of the gene for dopa-responsive dystonia

✍ Hirohide Takahashi; Robert A. Levine; Matthew P. Galloway; Barry J. Snow; Donald 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Role of SCA2 mutations in early- and lat

Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism

✍ Norman Kock; Birgitt Müller; Peter Vieregge; Peter P. Pramstaller; Karen Marder; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

Dopa-responsive dystonia and early-onset

Dopa-responsive dystonia and early-onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?

✍ Lena Elisabeth Hjermind; Lis Gitte Johannsen; Nenad Blau; Ron Allan Wevers; Chri 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

We describe a patient with a combination of dystonic and parkinsonian signs. Paraclinical studies revealed a mutation in the GTP cyclohydrolase I gene (GCH1) and a decrease in [ 123 I]-N--fluoropropyl-2␤-carbomethoxy-3␤-(4iodophenyl) nortropane ( 123 I-FP-CIT) binding ratios indicative of Parkinson'